Mafosfamide, a cyclophosphamide analog, causes a proinflammatory response and increased permeability on endothelial cells in vitro BONE MARROW TRANSPL
Genetic variants of CTLA4 are associated with clinical outcome of patients with multiple myeloma Front Immunol
Feasibility of a New Model of Care for Allogeneic Stem Cell Transplantation Recipients Facilitated by eHealth: The MY-Medula Pilot Study TRANSPL CELL THER
Exploring the Long-Term Tissue Accumulation and Excretion of 3 nm Cerium Oxide Nanoparticles after Single Dose Administration ANTIOXIDANTS-BASEL
Accuracy and prognostic impact of FDG PET/CT and biopsy in bone marrow assessment of follicular lymphoma at diagnosis: A Nation-Wide cohort study CANCER MED-US
Real-World Validation of Molecular International Prognostic Scoring System for Myelodysplastic Syndromes J Clin Oncol
Overall Survival With Daratumumab, Lenalidomide, and Dexamethasone in Previously Treated Multiple Myeloma (POLLUX): A Randomized, Open-Label, Phase III Trial J Clin Oncol
Daratumumab, carfilzomib, and dexamethasone in relapsed or refractory myeloma: final analysis of PLEIADES and EQUULEUS BLOOD CANCER J